These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9228040)

  • 21. Control of estrogen receptor ligand binding by Hsp90.
    Fliss AE; Benzeno S; Rao J; Caplan AJ
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):223-30. PubMed ID: 10822011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular chaperone HSP90 as a novel target for cancer chemotherapy].
    Miyata Y
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):33-42. PubMed ID: 12617036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
    Yun BG; Matts RL
    Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
    Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
    Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
    Schnaider T; Somogyi J; Csermely P; Szamel M
    Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains.
    Kakar M; Kanwal C; Davis JR; Li H; Lim CS
    AAPS J; 2006 Nov; 8(4):E718-28. PubMed ID: 17233535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents.
    Miyata Y
    Curr Pharm Des; 2005; 11(9):1131-8. PubMed ID: 15853661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.
    Neckers L; Schulte TW; Mimnaugh E
    Invest New Drugs; 1999; 17(4):361-73. PubMed ID: 10759403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1.
    Kanelakis KC; Murphy PJ; Galigniana MD; Morishima Y; Takayama S; Reed JC; Toft DO; Pratt WB
    Biochemistry; 2000 Nov; 39(46):14314-21. PubMed ID: 11087380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis.
    Gausdal G; Gjertsen BT; Fladmark KE; Demol H; Vandekerckhove J; Døskeland SO
    Leukemia; 2004 Dec; 18(12):1989-96. PubMed ID: 15483679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone receptor deficient in chromatin binding has an altered cellular state.
    Botos J; Xian W; Smith DF; Smith CL
    J Biol Chem; 2004 Apr; 279(15):15231-9. PubMed ID: 14744870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
    Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
    Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery.
    Kanelakis KC; Morishima Y; Dittmar KD; Galigniana MD; Takayama S; Reed JC; Pratt WB
    J Biol Chem; 1999 Nov; 274(48):34134-40. PubMed ID: 10567384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
    Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
    J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin recycling of glucocorticoid receptors: implications for multiple roles of heat shock protein 90.
    Liu J; DeFranco DB
    Mol Endocrinol; 1999 Mar; 13(3):355-65. PubMed ID: 10076993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent.
    Smith DF; Whitesell L; Nair SC; Chen S; Prapapanich V; Rimerman RA
    Mol Cell Biol; 1995 Dec; 15(12):6804-12. PubMed ID: 8524246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin.
    Sugita T; Tanaka S; Murakami T; Miyoshi H; Ohnuki T
    Biochem Mol Biol Int; 1999 Apr; 47(4):587-95. PubMed ID: 10319410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors.
    Beliakoff J; Bagatell R; Paine-Murrieta G; Taylor CW; Lykkesfeldt AE; Whitesell L
    Clin Cancer Res; 2003 Oct; 9(13):4961-71. PubMed ID: 14581371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus.
    Galigniana MD; Radanyi C; Renoir JM; Housley PR; Pratt WB
    J Biol Chem; 2001 May; 276(18):14884-9. PubMed ID: 11278753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.